Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
CELU
#3620
Celularity Inc. Class A Common Stock
1.2
1
0.00%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
0.00%
Changement Mensuel
-4.72%
Evolution sur 6 mois
-69.67%
Changement Annuel
-3.20%
Clôture Précédente
1.2
1
Open
1.2
1
Bid
Ask
Low
1.2
1
High
1.2
1
Volume
3
Marchés
Actions des Marchés US
Soins de Santé
CELU
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
2.88 M
13.77 M
16.5 M
21.98 M
22.55 M
99.32 M
Valuation ratios
Enterprise value
—
—
—
—
49.08 M
204.93 M
Price to earnings ratio
—
—
—
—
-0.79
-2.74
Price to sales ratio
—
—
—
—
0.84
3.77
Price to cash flow ratio
—
—
—
—
7.11
42.3
Price to book ratio
—
—
—
—
5.15
7.42
Enterprise value to EBITDA ratio
—
—
—
—
-1.58
-5.33
Profitability ratios
Return on assets %
0.01
0.24
0.04
1.36
0.44
0.66
Return on equity %
0.53
1.01
0.07
4.79
6.55
7.2
Return on invested capital %
5.34
133.77
26.65
266.54
104.97
155.54
Gross margin %
100
54.76
9.4
29.66
72.36
163.13
Operating margin %
-308.66
511.17
142.42
844.44
70.75
663.66
EBITDA margin %
—
-1 367.35
-1 495.69
-1 580.95
-57.33
-589.45
Net margin %
-192.39
469.27
78.95
862.04
106.77
1 110.46
Liquidity ratios
Quick ratio
—
1.89
0.45
0.21
0.28
0.86
Current ratio
0.11
2.25
0.54
0.29
0.38
1.17
Inventory turnover
—
16.72
19.41
15.82
6.87
6.7
Asset turnover
-0
0.06
0.04
0.08
0.39
0.32
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
9.2
2.17
0.29
0.25
EBIT per share
—
—
-18.57
-20.73
-1.78
-2.12
EBITDA per share
—
—
-17.94
-20.21
-1.42
-1.81
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
0.93
0.01
0.03
0.09
Net current asset value per share
—
—
2.24
1.11
0.94
3
Tangible book value per share
—
—
-2.79
1.27
-0.35
-0.23
Working capital per share
—
—
-1.91
-2.67
-1.51
-7.31
Book value per share
—
—
13.28
2.3
0.4
2.46
Nouvelles
Celularity reçoit 12,2 millions de dollars de la vente de crédits d’impôt
Celularity receives $12.2 million from sale of tax credits
Le cours de Celularity chute après le retrait des LCD sur les substituts cutanés par CMS
Celularity stock drops after CMS withdraws skin substitute LCDs
Medicare retire les modifications de couverture des substituts cutanés prévues pour 2026
Medicare withdraws skin substitute coverage changes set for 2026
Celularity obtient un financement de 10 millions de dollars du cofondateur de DoubleLine
Celularity secures $10 million financing from DoubleLine co-founder
Celularity obtient jusqu’à 12 millions de dollars de financement pour se concentrer sur la longévité
Celularity secures up to $12 million in financing for longevity focus
Celularity’s diabetic foot ulcer therapy shows promise in clinical trial
Celularity stock rating upgraded to Buy by WBB Securities on CMS reimbursement changes